Japan's Takeda teams up with Evozyne to develop next-gen gene therapies

US-based Evozyne, Inc., an adaptive biology company pioneering evolution-based design of proteins, founded by Paragon Bi...

April 11, 2022 | Monday | News
PENTAX Medical appoints Dr Klaus Mergener as Chief Medical Officer

Japan's PENTAX Medical, a division of HOYA Group, has announced the appointment of Dr Klaus Mergener to the po...

April 11, 2022 | Monday | News
AGC to expand synthetic pharmaceutical production base in Spain

AGC Inc., a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand ...

April 8, 2022 | Friday | News
CEPI partners with Japan’s NEC Group for AI-designed betacoronavirus vaccine

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...

April 8, 2022 | Friday | News
Japan's Shionogi accelerates R&D for data-driven innovation in pharmaceuticals

Japanese pharmaceutical company Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics ca...

April 7, 2022 | Thursday | News
Iktos, Teijin Pharma to co-develop new technology for small molecule drug discovery

French firm Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Japan's Teij...

April 6, 2022 | Wednesday | News
Chugai, Halozyme Therapeutics partner for ENHANZE Technology

US' Halozyme Therapeutics has announced a global collaboration and license agreement with Japan's Chugai Pharmaceutical ...

April 4, 2022 | Monday | News
Otsuka and Akebia seek USFDA approval for renal anemia drug

Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...

April 1, 2022 | Friday | News
HOYA Group appoints Rainer Burkard as global president of PENTAX Medical

PENTAX Medical, a division of HOYA Group, has announced the appointment of Rainer Burkard to the position of Global Pres...

April 1, 2022 | Friday | News
Terumo and Glooko collaborate on new solution for diabetes data sharing

Japan's Terumo Corporation and US-based Glooko have announced a technology integration to deliver new diabetes...

March 31, 2022 | Thursday | News
Japan grants marketing authorisation to Sanofi's rare disease drug

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorisation for Xenpozyme (olipu...

March 30, 2022 | Wednesday | News
Japan approves Tarlige tablets for treatment of patients with neuropathic pain

Daiichi Sankyo Company has obtained approval in Japan to change the indication of the analgesic 'Tarlige Tablets' (mirog...

March 29, 2022 | Tuesday | News
Takeda’s TAKHZYRO (lanadelumab) approved in Japan

Takeda has received approval from the Ministry of Health, Labour and Welfare (MHLW) for TAKHZYRO (lanadelumab) subc...

March 29, 2022 | Tuesday | News
Taiwan's Health2Sync partners with Novo Nordisk Pharma

Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate c...

March 28, 2022 | Monday | News
Hyperflex balloon catheter by Endovastec receives marketing approval in Japan

Shanghai MicroPort Endovascular MedTech has received registration approval from Japan Pharmaceuticals and Medical Device...

March 28, 2022 | Monday | News
TANAKA develops gold shell nanoparticles using high dispersion stability

TANAKA Kikinzoku Kogyo KK which operates the TANAKA precious metals manufacturing business announced that TANAKA has dev...

March 26, 2022 | Saturday | News
Japan verifies use of AI for retrosynthetic analysis in pharma applications

Japan-based Elix, Inc., an AI drug discovery company, has commenced joint research on the retrosynthetic analysis module...

March 25, 2022 | Friday | News
Fujifilm buys Shenandoah Biotechnology to strengthen life sciences biz

Japan-based FUJIFILM Corporation has announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development ...

March 23, 2022 | Wednesday | News